ChartMill assigns a Buy % Consensus number of 85% to KLRS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-03 | Citizens | Initiate | Market Outperform |
| 2025-09-03 | Raymond James | Initiate | Strong Buy |
| 2025-04-08 | William Blair | Initiate | Outperform |
11 analysts have analysed KLRS and the average price target is 17.34 USD. This implies a price increase of 194.65% is expected in the next year compared to the current price of 5.885.
The consensus rating for KALARIS THERAPEUTICS INC (KLRS) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.